These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 12225359)

  • 1. Immunological weapons against acute myeloid leukaemia.
    Galea-Lauri J
    Immunology; 2002 Sep; 107(1):20-7. PubMed ID: 12225359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunotherapy of acute myeloid leukemias: development of vaccines and cell therapy approaches].
    Mohty M; Gaugler B; Calmels B; Blaise D; Vey N; Chabannon C; Olive D
    Bull Cancer; 2003; 90(8-9):751-7. PubMed ID: 14609765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental approaches in immunological control of acute myelogenous leukaemia.
    Torelli GF; Orsini E; Guarini A; Kell J; Foà R
    Best Pract Res Clin Haematol; 2001 Mar; 14(1):189-209. PubMed ID: 11355931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immune edited tumour versus a tumour edited immune system: Prospects for immune therapy of acute myeloid leukaemia.
    Chan L; Hardwick NR; Guinn BA; Darling D; Gäken J; Galea-Lauri J; Ho AY; Mufti GJ; Farzaneh F
    Cancer Immunol Immunother; 2006 Aug; 55(8):1017-24. PubMed ID: 16450142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy of acute myeloid leukemia: current approaches.
    Smits EL; Berneman ZN; Van Tendeloo VF
    Oncologist; 2009 Mar; 14(3):240-52. PubMed ID: 19289488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translational mini-review series on vaccines: Peptide vaccines for myeloid leukaemias.
    Barrett AJ; Rezvani K
    Clin Exp Immunol; 2007 May; 148(2):189-98. PubMed ID: 17437417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cell-based immunotherapy in acute and chronic myeloid leukaemia.
    Westers TM; Ossenkoppele GJ; van de Loosdrecht AA
    Biomed Pharmacother; 2007 Jul; 61(6):306-14. PubMed ID: 17368821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide vaccines for myeloid leukaemias.
    Dao T; Scheinberg DA
    Best Pract Res Clin Haematol; 2008 Sep; 21(3):391-404. PubMed ID: 18790445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cell vaccines for leukemia patients.
    Schmitt A; Hus I; Schmitt M
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):275-83. PubMed ID: 17338648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cell-based immunotherapy in myeloid leukaemia: translating fundamental mechanisms into clinical applications.
    van de Loosdrecht AA; van den Ancker W; Houtenbos I; Ossenkoppele GJ; Westers TM
    Handb Exp Pharmacol; 2009; (188):319-48. PubMed ID: 19031033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer immune therapy for myeloid malignancies: present and future.
    Holmström MO; Hasselbalch HC
    Semin Immunopathol; 2019 Jan; 41(1):97-109. PubMed ID: 29987478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for acute myeloid leukemia (AML): a potent alternative therapy.
    Acheampong DO; Adokoh CK; Asante DB; Asiamah EA; Barnie PA; Bonsu DOM; Kyei F
    Biomed Pharmacother; 2018 Jan; 97():225-232. PubMed ID: 29091870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy for paediatric leukaemia.
    Rousseau RF; Bollard CM; Heslop HE
    Expert Opin Biol Ther; 2001 Jul; 1(4):663-74. PubMed ID: 11727502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I/II study of vaccination with dendritic-like leukaemia cells for the immunotherapy of acute myeloid leukaemia.
    Roddie H; Klammer M; Thomas C; Thomson R; Atkinson A; Sproul A; Waterfall M; Samuel K; Yin J; Johnson P; Turner M
    Br J Haematol; 2006 Apr; 133(2):152-7. PubMed ID: 16611305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy of myeloid leukaemia.
    Guinn BA; Mohamedali A; Thomas NS; Mills KI
    Cancer Immunol Immunother; 2007 Jul; 56(7):943-57. PubMed ID: 17180671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy in acute myeloid leukemia.
    Grosso DA; Hess RC; Weiss MA
    Cancer; 2015 Aug; 121(16):2689-704. PubMed ID: 26095886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of acute myeloid leukemia.
    Frankel AE; Baer MR; Hogge DE; Stuart RK
    Curr Pharm Biotechnol; 2001 Sep; 2(3):209-15. PubMed ID: 11530875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches in the immunotherapy of haematological malignancies.
    Costello RT; Rey J; Fauriat C; Gastaut JA; Olive D
    Eur J Haematol; 2003 May; 70(5):333-45. PubMed ID: 12694173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute myeloid leukemia and novel biological treatments: monoclonal antibodies and cell-based gene-modified immune effectors.
    Tettamanti S; Magnani CF; Biondi A; Biagi E
    Immunol Lett; 2013; 155(1-2):43-6. PubMed ID: 24076117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy with acute leukemia cells modified into antigen-presenting cells: ex vivo culture and gene transfer methods.
    Stripecke R; Levine AM; Pullarkat V; Cardoso AA
    Leukemia; 2002 Oct; 16(10):1974-83. PubMed ID: 12357348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.